March 2008: Biotech bounces back
December 2007/January 2008: A question of convergence
October 2007: Biotech bounces back
July 2007: Efficiency in selection
April 2007: Chiral at the core
March 2007: NCEs tackle lifestyle diseases
November 2006: Divide and rule
September 2006: A jab to beat cancer?
May 2006: Enzymes to the rescue
March 2006: Prevalent infections beaten by new approvals
December 2005/January 2006: Drug designers factor in gene type
November 2005: Cutting the cost of chiral production
September 2005: Could MAbs be the 'magic bullet'?
June 2005: Rx-DX: the way ahead for drugs
May 2005: Biologics build a better base
April 2005: Pure perfection
March 2005: Approvals continue to fall
February 2005: Trials transparency
January 2005: Quality questions
October 2004: The rise of chiral chemistry
August 2004: Radiopharmaceuticals - a new lease of life for biopharma?
June 2004: Ionic liquids for greener processes
February 2004: Another year of drug innovations
January 2004: From steroids to antibodies: treating psoriasis
December 2003: The power of RNAi in drug discovery
October 2003: Investigating the potential of hydroformylation
August 2003: Herbal medicines: are they really the safer option?
May 2003: Snipping away at the causes of disease
April 2003: SPR determinations aid water purity
March 2003: Another year of drug innovations
February 2003: Blocking the way forward
January 2003: Efficient synthesis
December 2002: Paying the price for protection
November 2002: Precious metals
October 2002: Expensive errors - the cost of getting it wrong
September 2002: Gut reactions - seeking new treatments for IBD
August 2002: Information overload
July 2002: EU drug discovery crisis?
June 2002: Cannabis - a medical miracle?
April 2002: A year of new drug treatments
March 2002: Cancer - a fertile field for drug development
February 2002: Pharmacogenomics - an individual approach
January 2002: Chiral switches
January 2002: Virtual reality - the rise of contract manufacturing
December 2001: Hidden anthrax risks
December 2001: Natural progression - biotechnology in chemical synthesis
November 2001: Creating chirally pure drugs by SMB chromatography
October 2001: Restrictive funding will slow research
October 2001: Statins - the answer to high cholesterol?
September 2001: Halting the progression of Alzheimer's disease
August 2001: Developing support for solid-phase chemistry